Orthofix Reports 3Q18 Revenue of $111.7MM, +6.1% vs. 3Q17

Orthofix’s 3Q18 performance was driven by their bone growth and trauma products with total revenue of $111.7MM, +6.1% vs. 3Q17. The company also made progress on their realigning their organizational structure, an initiative leadership expects to improve performance of the spine and orthobiologics segments.

Top Line Growth Amid...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us